Mutton fat-processing enhances the anti-osteoporotic effect of Epimedium koreanum Nakai via regulating the metabolism-inflammation-bone axis.
Mutton fat-processing of Epimedii Folium enhances its anti-osteoporotic effects in preclinical models, suggesting potential benefits in bone health management.
Where it sits
this study against the rest of the vip (vasoactive intestinal polypeptide) corpusSummary and findings
This study examined the anti-osteoporotic effects of raw versus mutton fat-processed Epimedii Folium in postmenopausal osteoporosis using cell and animal models. The processed form showed enhanced efficacy in improving bone mass, trabecular structure, and osteogenesis. Mechanistic insights included regulation of glycerophospholipid metabolism and inflammatory signaling pathways.
Abstract
<h4>Ethnopharmacological relevance</h4>Epimedium koreanum Nakai is a well-recognized tonic herb in traditional Chinese medicine that has been extensively used for thousands of years in the management of bone metabolic diseases. According to classic traditional Chinese medicine processing principles, stir-frying Epimedii Folium with mutton fat can synergistically augment its "kidney-warming and bone-strengthening" therapeutic effects. However, the modern pharmacological basis and precise molecular mechanisms underlying this processing-enhanced efficacy remain largely unexplored.<h4>Aim of the study</h4>This study aimed to compare the anti-osteoporotic effects of raw and mutton fat-processed Epimedii Folium in postmenopausal osteoporosis, and to reveal the underlying mechanisms.<h4>Materials and methods</h4>Multiple techniques were applied, including ultra performance liquid chromatography coupled with Q Exactive mass spectrometry, network pharmacology, cell and animal models, non-targeted metabolomics, Western blot analysis, and quantitative real-time reverse transcription polymerase chain reaction. These approaches enabled component analysis, mechanism prediction, and multi-level in vitro and in vivo validation.<h4>Results</h4>Processed Epimedii Folium contained more blood-absorbed constituents, and more effectively improved bone mass, trabecular structure, osteoclast activity and osteogenesis. It regulated glycerophospholipid metabolism, inhibited inflammatory signaling, and relieved stress on the osteoprotegerin/receptor activator of nuclear factor-κB ligand axis to restore bone homeostasis.<h4>Conclusion</h4>Mutton fat-processed Epimedii Folium exerts anti-osteoporotic effects through a "metabolic remodeling-inflammation inhibition-bone homeostasis restoration" axis. This study provides modern scientific evidence for the processing method of Epimedium recorded in the Chinese Pharmacopoeia, and offers a valuable paradigm for research on traditional Chinese medicine processing.
Background
The study investigates the anti-osteoporotic effects of Epimedium koreanum Nakai, a traditional Chinese medicine known for its bone-strengthening properties. Traditional processing with mutton fat is believed to enhance these effects, but the modern pharmacological basis for this enhancement is not well understood. Understanding these mechanisms could validate traditional practices and inform modern therapeutic strategies.
Methods
The study employed a combination of ultra performance liquid chromatography, mass spectrometry, network pharmacology, and both in vitro and in vivo models. Techniques included non-targeted metabolomics, Western blot analysis, and quantitative real-time PCR. The focus was on comparing raw and processed Epimedii Folium in terms of their effects on bone health in postmenopausal osteoporosis models.
Results
The processed Epimedii Folium demonstrated superior efficacy in improving bone mass and trabecular structure, as well as enhancing osteoclast activity and osteogenesis. It was found to regulate glycerophospholipid metabolism and inhibit inflammatory signaling, contributing to the restoration of bone homeostasis. These findings suggest a potential mechanism involving metabolic remodeling and inflammation inhibition.
Interpretation
While the study provides insights into the enhanced effects of processed Epimedii Folium, the reliance on animal and cellular models limits the direct translation to human clinical practice. The absence of quantitative data on effect sizes in the abstract makes it difficult to assess the clinical significance. However, the findings align with traditional beliefs and offer a scientific basis for the processing method.
Key findings
- Processed Epimedii Folium contained more blood-absorbed constituents.
- Improved bone mass and trabecular structure observed in processed form.
- Enhanced osteoclast activity and osteogenesis with processing.
- Regulation of glycerophospholipid metabolism noted.
- Inhibition of inflammatory signaling pathways reported.
Limitations
- animal and cell models only
- quantitative effects not detailed
- mechanistic insights may not translate directly to humans
- traditional processing method not standardized